About Andrew Schwab
Form D filings for Radionetics Oncology in 2023 list Andrew Schwab as director.
Andrew Schwab first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Andrew Schwab in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Andrew Schwab works with at each company, as listed on that company's latest Form D.
Radionetics Oncology, Inc. · Form D, Aug 15, 2023
BE
Brett Ewald
Interim Chief Operating Officer
UG
Umesh Gangadharmath
Executive officer
DE
Dan Estes
Executive officer and director
IM
Istvan Molnar
Executive officer
YZ
Yunfei Zhu
Executive officer
AK
Ana Kusnetzow
Executive officer
SS
Scott Struthers
Director